Search results
Annovis Bio, Inc. (NYSE:ANVS) Shares Sold by Merit Financial Group LLC
ETF DAILY NEWS· 3 days agoMerit Financial Group LLC decreased its holdings in Annovis Bio, Inc. (NYSE:ANVS – Free Report) by 46.1% in the fourth quarter, according to its most recent ...
Catalyst (CPRX) Q1 Earnings Beat, Firdapse Sales Drive Revenues
Zacks via Yahoo Finance· 1 day agoQuote Regulatory Update In October 2023, the FDA accepted CPRX’s... LGND, ANI Pharmaceuticals ANIP...
Annovis Bio CEO Maria Maccecchini Issues Letter to Stockholders - Annovis Bio (NYSE:ANVS)
Benzinga· 5 days agoAnnovis Bio, Inc. ANVS ("Annovis" or the "Company"), a clinical-stage drug platform company developing novel therapies for neurodegenerative diseases, announced ...